VF
DSGN icon

Virtu Financial’s Design Therapeutics DSGN Stock Holding History

Virtu Financial’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,651
Closed -$212K – 1781
2025
Q4 		$212K Buy
+22,651
New +$177K 0.01% 991
2024
Q4 		– Sell
-46,356
Closed -$249K – 1661
2024
Q3 		$249K Buy
46,356
+35,286
+319% +$166K 0.01% 711
2024
Q2 		$37K Buy
+11,070
New +$43.1K ﹤0.01% 943

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Virtu Financial's DSGN Position: Q1 2026 in Review

Virtu Financial sold out of Design Therapeutics (DSGN) in Q1 2026, closing a stake of 22,651 shares — an estimated $212K sold.

Virtu Financial first reported a position in DSGN in Q2 2024 and held it in 3 quarters. The position peaked at $249K in Q3 2024. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • Virtu Financial reported no remaining Design Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 22,651 Design Therapeutics shares in Q1 2026, an estimated $212K.
  • Virtu Financial first reported a position in Design Therapeutics in Q2 2024 and held it in 3 quarters.
  • Virtu Financial's Design Therapeutics position peaked at $249K in Q3 2024.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.